These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7658706)

  • 1. Correlation of elevated plasma soluble IL-2 receptor levels with defective NK and CD8+ T-cells in myelodysplastic syndromes: is it part of a spectrum?
    Demeter J; Schmid M; Vargha P; Porzsolt F
    Leuk Res; 1995 Aug; 19(8):583-4. PubMed ID: 7658706
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-2 therapy for myelodysplastic syndrome: does it work?
    Ogata K; Yokose N; Nomura T
    Leuk Lymphoma; 1995 May; 17(5-6):411-5. PubMed ID: 7549831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels.
    Boyiadzis M; Memon S; Carson J; Allen K; Szczepanski MJ; Vance BA; Dean R; Bishop MR; Gress RE; Hakim FT
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):290-300. PubMed ID: 18275895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
    Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
    Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma soluble interleukin 2 receptor level correlates with defective natural killer and CD8+ T-cells in myelodysplastic syndromes.
    Yokose N; Ogata K; Ito T; An E; Tamura H; Dan K; Hamaguchi H; Sakamaki H; Onozawa Y; Nomura T
    Leuk Res; 1994 Oct; 18(10):777-82. PubMed ID: 7934136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma soluble interleukin-2 receptors in patients with myelodysplastic syndromes.
    Yokose N; Ogata K
    Leuk Lymphoma; 1997 Dec; 28(1-2):171-6. PubMed ID: 9498716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of NK and CD8
    White EJ; Trigatti BL; Igdoura SA
    J Neuroimmunol; 2017 May; 306():55-67. PubMed ID: 28385189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective natural killer (NK) cell-mediated cytotoxicity does not imply clonal involvement of NK cells in myelodysplastic syndromes.
    Ogata K; Fujii H; Yokose N; An E; Tamura H; Kamikubo K; Dan K; Hamaguchi H; Sakamaki H; Onozawa Y
    Br J Haematol; 1994 Jun; 87(2):396-8. PubMed ID: 7947284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Professional killer cell deficiencies and decreased survival in pulmonary arterial hypertension.
    Edwards AL; Gunningham SP; Clare GC; Hayman MW; Smith M; Frampton CM; Robinson BA; Troughton RW; Beckert LE
    Respirology; 2013 Nov; 18(8):1271-7. PubMed ID: 23819819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of soluble interleukin-2 receptors and tumor necrosis factor in serum of patients with myelodysplastic syndromes.
    Zoumbos N; Symeonidis A; Kourakli A; Katevas P; Matsouka P; Perraki M; Georgoulias V
    Blood; 1991 Jan; 77(2):413-4. PubMed ID: 1985704
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes.
    Kiladjian JJ; Visentin G; Viey E; Chevret S; Eclache V; Stirnemann J; Bourhis JH; Chouaib S; Fenaux P; Caignard A
    Haematologica; 2008 Mar; 93(3):381-9. PubMed ID: 18268282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of CD57+ natural killer cells and CD8+ T lymphocytes in periapical granulomas and radicular cysts.
    Silva LABD; Sá MAR; Melo RA; Pereira JDS; Silveira ÉJDD; Miguel MCDC
    Braz Oral Res; 2017 Dec; 31():e106. PubMed ID: 29267667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
    Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure.
    Maciejewski JP; Hibbs JR; Anderson S; Katevas P; Young NS
    Exp Hematol; 1994 Oct; 22(11):1102-10. PubMed ID: 7925777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune status of Fanconi anemia patients: decrease in T CD8 and CD56dim CD16+ NK lymphocytes.
    Justo GA; Bitencourt MA; Pasquini R; Castelo-Branco MT; Almeida-Oliveira A; Diamond HR; Rumjanek VM
    Ann Hematol; 2014 May; 93(5):761-7. PubMed ID: 24240977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and Vbeta repertoire characterization of human CD8+ T-cell subsets with natural killer cell markers, CD56+ CD57- T cells, CD56+ CD57+ T cells and CD56- CD57+ T cells.
    Takayama E; Koike Y; Ohkawa T; Majima T; Fukasawa M; Shinomiya N; Yamaguchi T; Konishi M; Hiraide H; Tadakuma T; Seki S
    Immunology; 2003 Feb; 108(2):211-9. PubMed ID: 12562330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL10 inversely correlates with the percentage of CD8⁺ cells in MDS patients.
    Lopes MR; Traina F; Campos Pde M; Pereira JK; Machado-Neto JA; Machado Hda C; Gilli SC; Saad ST; Favaro P
    Leuk Res; 2013 May; 37(5):541-6. PubMed ID: 23453286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II trial of interleukin-2 in myelodysplastic syndromes.
    Nand S; Stock W; Stiff P; Sosman J; Martone B; Radvany R
    Br J Haematol; 1998 Apr; 101(1):205-7. PubMed ID: 9576203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The JAK2V617F mutation is associated with anomalies in the frequency of monocytes, B cells, CD8+ T cells and NK cells.
    Costa-Brito AR; Cardoso EM; Martinez J; Arosa FA
    Blood Cells Mol Dis; 2015 Oct; 55(3):208-10. PubMed ID: 26227846
    [No Abstract]   [Full Text] [Related]  

  • 20. IL-15 has innate anti-tumor activity independent of NK and CD8 T cells.
    Davies E; Reid S; Medina MF; Lichty B; Ashkar AA
    J Leukoc Biol; 2010 Sep; 88(3):529-36. PubMed ID: 20538758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.